A Study of GW685698X 100mcg Administered Once Daily Either in the Morning or the Evening and GW685698X 250mcg Administered Once Daily in the Evening Via DISKHALER for 28 Days in Subjects With Persistent Bronchial Asthma.
Clinical trial NCT01499446 · COMPLETED
Trial details
- NCT number
- NCT01499446
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-09-01
- Primary completion
- 2004-03-01
- Enrollment
- 669
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.